Anna Titkova
International Operations Director, Pratia & Country Head Ukraine
Key Points
- Trust and communication are key to successful site networks
- True patient-centricity shines during crises, requiring flexibility
- Long-term relationships mitigate risks and enhance stability
- Evaluate sites on process quality and patient experience, not just metrics
- Empowering staff with ownership fosters proactive problem-solving
Tom Lazenby interviews Anna Titkova, Clinical Research Site Network Leader at Pratia, about site networks, culture, and what patient-centricity actually costs when it stops being a slide and becomes a decision. They discuss why enrolment numbers are a lagging indicator and which leading indicators truly predict a good site, how the real gap between sites and sponsors is communication and trust rather than capability, and what happened when the war reached Ukraine and clinical trials stopped overnight. Anna shares how she and her teams moved oncology patients across borders to keep them on treatment, the one capability that separates a high-performing site from an average one, and how protocol complexity quietly becomes a barrier to recruitment and retention. Having built a clinical research site in Ukraine before the invasion forced her to rebuild across eight European countries, Anna offers the practical realities of site-network leadership and what genuine partnership between sponsors, CROs, and sites looks like in practice.
Chapters
About the Guest
Anna Titkova
International Operations Director, Pratia & Country Head Ukraine
Anna Titkova, MD, PhD, Professor Assoc., MBA, is International Operations Director at Pratia and Country Head for Ukraine.
Anna graduated from Kharkiv National Medical University and works as Assoc. Professor and researcher at Dnipro Institute of Medicine and Public Health. She has a PhD, Master of Medical and Educational Sciences, MBA, completed an internship at Harvard and Yale Universities, and is a qualified international lecturer and senior researcher. In March 2020, Anna opened Pratia Ukraine LLC and the first SMO clinical research site, Pratia Clinic Ukraine, part of the international site network Pratia under the umbrella of the NEUCA group. Her company works with 10 medical institutions in 3 Ukrainian regions in the clinical trials field.
From 2022 she combines her local activities with international operations within the Pratia network of clinical research sites in 8 European countries.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.